Featured Research

from universities, journals, and other organizations

New Fertility Guidelines Limit Embryo Transfers

Date:
October 25, 2006
Source:
March of Dimes Birth Defects Foundation
Summary:
New fertility treatment guidelines from the American Society of Reproductive Medicine call for a limited number of embryos -- in some cases only one -- to be transferred during in-vitro fertilization procedures. These new guidelines will reduce the risk of a multiple gestation and the risk of complications for the mother and fetus, including pre-term birth.

The March of Dimes applauds new fertility treatment guidelines from the American Society of Reproductive Medicine (ASRM) calling for a limited number of embryos -- in some cases only one -- to be transferred during in-vitro fertilization procedures.

"Limiting the number of transferred embryos will mean fewer higher-order multiple gestations, defined as three or more fetuses, and reduce the risk of complications for both the mother and the fetus, including preterm birth," said Dr. Nancy Green, March of Dimes medical director. "New parents may think there's more to love when you have more than one baby, but there's also more to worry about; more than half of twins and nearly all triplets are born prematurely, associated with an increased risk of death and disability."

About 12.5 percent of U.S. babies are born too soon (before 37 completed weeks gestation) each year and babies who survive face risks of lifelong health challenges.

The March of Dimes, the American College of Obstetricians and Gynecologists and ASRM issued a first-ever joint consumer document stressing the importance of reducing the risk of a preterm birth for women undergoing fertility treatments.

More than one-third of pregnancies conceived using assisted reproductive therapies (transferring a fertilized egg into a uterus) result in a multiple birth. Pregnancies conceived using ovarian hyper-stimulation drugs, which accelerate egg production, often result in a multiple birth. Women considering these 'fertility drugs' should consult a specialist prior to using them.

The March of Dimes also suggested additional steps, beyond the ASRM guidelines, to help women make informed decisions about fertility treatments:

  • Require informed consent documents include explicit information about the risk of multiples and premature birth.
  • Require annual review of clinics' performance and publish a list of those with highest and lowest rates of higher-order multiple births.

"Consumers should demand quality assurance in the fertility business, just as they do in other aspects of health care," says Dr. Green. "Women should ask about a center's multiple birth rate, ensure it follows the guidelines and reports results to the Society for Assisted Reproductive Technology."

Information is available from the U.S. Centers for Disease Control and Prevention at http://www.cdc.gov/reproductivehealth/art.htm.


Story Source:

The above story is based on materials provided by March of Dimes Birth Defects Foundation. Note: Materials may be edited for content and length.


Cite This Page:

March of Dimes Birth Defects Foundation. "New Fertility Guidelines Limit Embryo Transfers." ScienceDaily. ScienceDaily, 25 October 2006. <www.sciencedaily.com/releases/2006/10/061025080633.htm>.
March of Dimes Birth Defects Foundation. (2006, October 25). New Fertility Guidelines Limit Embryo Transfers. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/10/061025080633.htm
March of Dimes Birth Defects Foundation. "New Fertility Guidelines Limit Embryo Transfers." ScienceDaily. www.sciencedaily.com/releases/2006/10/061025080633.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins